Submit Your Article CMED MEACR meeting
Home Print this page Email this page Users Online: 770
Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 


 
 Table of Contents  
ORIGINAL ARTICLE
Year : 2018  |  Volume : 7  |  Issue : 4  |  Page : 127-131

Outcomes of bladder cancer undergoing radical cystectomy: A single-institution experience


Department of Urology, R. G. Kar Medical College and Hospital, Kolkata, West Bengal, India

Date of Web Publication24-Dec-2018

Correspondence Address:
Dr. Md Dawood Khan
Department of Urology, R. G. Kar Medical College, Khudiram Bose Sarani, Shyaam Bazar, Kolkata, West Bengal
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/ccij.ccij_68_18

Rights and Permissions
  Abstract 


Objectives: The objective of the study is to evaluate the functional outcome and postoperative complications of patients with bladder cancer undergoing radical cystectomy. Methods: This was a prospective, single-center study conducted between January 2013 and October 2016. Patients of either sex, aged more than 18 years, diagnosed with bladder cancer and treated with radical cystectomy and urinary diversion were enrolled in this study. Demographic and clinical characteristics, therapy and functional outcome details, and details of complications were collected. Results: A total of 94 patients were enrolled in the study. Overall, the mean age was 53.11 years and 74 (78.72%) patients were male. Of the 94 patients, 61 patients underwent radical cystectomy with ileal conduit (IC) and 30 patients had orthotopic neobladder. The sigmoid diversion was done in two patients, and one patient had a continent diversion. Four patients succumbed to mortality. Two patients had a recurrence at the urethral margin in IC patients. The functional outcome was found to be better in the neobladder group compared to the IC group. Conclusion: This study provides extensive information on outcomes of bladder cancer undergoing radical cystectomy. Studer's neobladder had slightly improved outcomes than IC.

Keywords: Ileal conduit, orthotopic neobladder, real-world study, Studer's neobladder, transitional cell carcinoma


How to cite this article:
Dey RK, Khan MD, Khan IA, Das RK. Outcomes of bladder cancer undergoing radical cystectomy: A single-institution experience. Clin Cancer Investig J 2018;7:127-31

How to cite this URL:
Dey RK, Khan MD, Khan IA, Das RK. Outcomes of bladder cancer undergoing radical cystectomy: A single-institution experience. Clin Cancer Investig J [serial online] 2018 [cited 2019 Oct 23];7:127-31. Available from: http://www.ccij-online.org/text.asp?2018/7/4/127/248463




  Introduction Top


Urinary bladder cancer is one of the most common cancers of the urinary tract worldwide. Approximately, 2.4% of men and women have the risk of developing bladder cancer at some point during their lifetime and around 4.4 per 100,000 die due to bladder cancer.[1] In India, as per the National Cancer Registry Programme, the overall incidence rate of the urinary bladder cancer was reported as 2.25% (per 100,000 annually); however, the rate in men was much higher (3.67%) than women (0.83%).[2] Bladder cancer has a significant impact on the quality of life (QoL) of patients and the health-care system and considering its treatment cost, it is one of the most expensive cancers. The standard treatment option for muscle-invasive bladder cancer, including extensive superficial bladder cancer, is radical cystectomy with pelvic lymphadenectomy and urinary diversion. The open procedure puts a break in term of cystoscopic surveillance of tumor but managing the conduit still takes the toll. Somani et al. evaluated if health and body image are important determinants of QoL 32 patients undergoing radical cystectomy and found that health and body image may not always be important to patients for their QoL.[3] This highlights that functional outcomes and complications need better understanding. It is also reported that survival and prognosis of patients with bladder cancer depend on age, gender, and racial factors.[4] Hence, in the present study, the functional outcome and postoperative complications of patients with bladder cancer undergoing radical cystectomy were evaluated in a real-world setting.


  Methods Top


This was a prospective, single-center study conducted between January 2013 and October 2016. Patients of either sex, aged more than 18 years, diagnosed with bladder cancer and treated with radical cystectomy and urinary diversion were enrolled in this study. The study protocol was approved by the Institutional Ethics Committee. Each study participant provided written informed consent before participation in the study. Each patient or their relatives also provided separate consent for the surgical procedure after counseling.

Patients who presented with hematuria were evaluated for the history of addiction and ultrasonography of kidney ureter bladder (KUB). Patients with the sonographic diagnosis of a mass in urinary bladder were subjected to contrast-enhanced computed tomography (CT) of the whole abdomen and pelvis. Patient having resectable mass underwent transurethral resection of a bladder tumor; however, patients with extensive bladder mass were limited to biopsy.

Based on the biopsy report and clinical staging, patients were treated with neoadjuvant chemotherapy. Ileal orthotopic neobladder (ONB) was done using a modified Studer technique. Ileal conduit (IC) with Bricker ureteric anastomosis was performed with the minimal amount of ileum. Few patients had Sigma rectum (SR) and continent diversion (CD). The choice of diversion was decided after evaluation of patient factors, surgeon's preference and experience in managing complications. Contraindication for ONB in the study was serum creatinine >2 mg/dL, chronic inflammatory bowel disease, history of previous bowel resection, tumor involvement at the bladder neck/prostatic urethra, and patient reluctance to perform a clean intermittent catheterization.

Data were collected regarding the demographic profile, histopathology of the specimen, pathological tumor stage, postoperative complications, adjuvant therapy, and relapse. The follow-up protocol consisted of renal function tests, liver function tests, urine culture, urine cytology, postvoid residual urine volume assessment (in the ONB group), and chest radiography every 3 months; urethral washing (in the IC group) and plain abdominal film of KUB every 6 months; and serum analysis for metabolic acidosis every 3 months for 1st year and then every 6–12 months' irrespective of pathological staging. In patients with pT2, N0 disease, CT urography was performed every 6 months for the first 2 years and annually thereafter; a bone scan was performed annually. In patients with >pT3 or pN+ disease, CT urography was performed at 3 months after radical cystectomy and every 6 months thereafter for the first 3 years and annually thereafter; a bone scan was carried out every 6 months. The functional outcome of all the patients was taken at 1 year of follow-up. Statistical analysis was done, and data were presented using summary statistics.


  Results Top


During the study, a total of 94 patients were treated with radical cystectomy. Overall, the mean age was 53.11 years and 74 (78.72%) patients were male. Most (n = 92 [98%]) of the patients had a history of tobacco consumption (smoking for males and betel nuts chewing in case of females). Of the total 94 patients, IC was performed in 61 (64.89%) patients, ileal ONB in 30 (31.91%) patients, SR in 2 (2.13%) patients and continent diversion in 1 (1.06%) patient. Mortality occurred in 4 (4.26%) patients, and all were from the IC group. The clinical stages were: T1 – 12.76% (n = 12), T2 – 76.59% (n = 72), T3 – 9.57% (n = 9), and T4 – 1.06% (n = 1). Neoadjuvant chemotherapy was given in 15 out of 94 patients (15.96%).

Histopathological examination revealed transitional cell carcinoma (TCC) in 89 (94.68%) patients, squamous cell carcinoma in 3 (3.19%) patients, small cell, and adenocarcinoma was found in 1 (1.06%) patient each. The urethral margin was positive in 2 (2.13%) patients and was negative in all other patients. The lymph node was positive in 8 (8.51%) patients. The R0 resection was possible in 87 (92.55%) patients, R1 in 4 (4.26%) patients, and R2 resection in 3 (3.19%) patients.

Major complications constituted 9.57% of the total patients whereas minor complications comprised 45.64%. The most common complication was wound infection reported in 28.89% of patients followed by urinary tract infection (12.22%) [Table 1]. The most common late complication was an incisional hernia (7.78%) followed by subacute intestinal obstruction (5.56%) [Table 2]. Mean hospital stay after surgery in the IC group and ONB group was 16.00 days and 22.53 days, respectively. SR had a mean hospital stay of 17.50 days, and patient with continent diversion stayed for 31 days.
Table 1: Summary of complications

Click here to view
Table 2: Summary of late complications

Click here to view


[Table 3] shows functional outcomes at 1 year. Overall, the bodily pain was reported in the majority (72.22%) of patients. Bowel symptoms were also reported in more than half of the patients (57.78%). Depression and social withdrawal were reported in 33.33% of patients. [Table 4] demonstrates improvement in bladder capacity and postvoid residual urine over 1 year.
Table 3: Summary of functional outcomes at 1 year

Click here to view
Table 4: Neobladder chart

Click here to view



  Discussion Top


This prospective, single-center study provides extensive information on real-world treatment of bladder cancer with radical cystectomy. Radical cystectomy and urinary diversions are the standard of care for extensive and muscle-invasive bladder cancer.[5],[6],[7],[8] The demographic profile of our patients was similar to that of patients from previous reports.[5],[6],[7],[8],[9],[10],[11] In our study, clinically muscle-invasive malignancy accounted for 82 (87.23%) cases. In a previous study, it has been reported that most of the urologists in India still preferred IC for the management of muscle-invasive bladder cancer.[12] Our results were consistent with this observation, where 57 (60.63%) of patients were managed with IC.

In the present study, the mean hospital stays of the IC group, ONB group, SR, and Mansoura pouch (CD) were 16 days, 22.5 days, 17.5 days, and 31 days. Major and minor complications were 9.57% and 45.64%, respectively, which was slightly higher than previous studies conducted at high-volume centers performing radical cystectomy.[5],[6],[7],[8],[9],[10],[11],[13],[14] Perioperative mortality was 4.5%, which was slightly more than other reports of 2%–3%.[5],[6],[7],[8],[9],[10],[11],[13],[14] In our study, 15.95% of patients received neoadjuvant therapy which shows a lack of penetrance of neoadjuvant chemotherapy in the setting of muscle-invasive disease.[15] A previous meta-analysis of 15 studies that included a total of 3285 patients supports the use of neoadjuvant chemotherapy in muscle-invasive bladder cancer.[16]

Wound infection was developed in 26 (28.89%) patients, and the urinary leak was developed in 7 (7.78%) patients. The lower incidence of urine leak in our study could be possibly due to early bladder wash by the diluted sodabicarb solution. One patient was found to have drain eroding into neobladder who underwent bilateral percutaneous nephrostomy. After the removal of drain detected on cystoscopy, the leak was stopped. A total of 10 patients developed urinary tract infection. Reoperation was done in six out of 94 patients, of which two were for neobladder fistula, and others were for burst abdomen. One patient had an intraoperative complication in the form of rectal injury and was repaired with a sigmoid colostomy. This patient underwent ONB and developed recto neobladder fistula. Finally, the patient was managed by conversion to the IC.

Histopathological examination in our study showed that TCC was the predominant histology. The urethral margin was positive in two patients and was negative in all other patients. The lymph node was positive in eight patients. These outcomes confirm the meticulous surgical dissection of the procedure. In our study, we did not come across any distant metastasis.

We found that our patients with an IC had significantly less trouble in controlling urine than those with an ONB. This observation was consistent with previous reports.[15],[17] Better stoma appliances and postoperative care by a skilled stoma therapist might have reduced the stoma-related problems. Some degree of urinary leakage, especially at night, is a consistent finding in ONB patients.[18]

Patients who were treated with IC have previously shown to have significant body image problems, and most of them are embarrassed due to the stoma.[19] These patients are generally less active and restrict themselves from social activities. About 33.33% of patients suffered from depression and social withdrawal whereas 36.84% belonged to IC group compared to 20.0% in ONB group.

Studer neobladder initially starts with a capacity of ~150 ml and increases up to 400–450 ml. Daytime continence greatly increased by Kegel exercise. Night time continence was significantly enhanced by advising patients to pass urine once in the middle of the night. Significant metabolic acidosis was not seen in the present study as the sodabicarb powder was given in the early postoperative period and as the shorter ileal segment was taken. In the present study, the urine leak was significantly less (7.78% of the total patients) due to early bladder wash by the diluted sodabicarb solution. Continence diversion is time-consuming and with inherent complications.

Ureterosigmoidostomy was done in an emergency situation in one patient, as the perioperative period was stormy. One patient with SR was operated as the patient was unable to bear the cost of ileostomy bag. Night time continence was significantly enhanced by using the rectal tube at night. In the follow-up of 90 patients, the late complications were encountered in the form of an incisional hernia. Renal deterioration, subacute intestinal obstruction occurred in four patients each in IC group and rectourethral fistula in a single patient of ONB group.

One patient from ONB group also suffered from subacute intestinal obstruction. One patient had a forgotten stent of IC patient and developed a renal stone, which was managed by percutaneous nephrolithotomy. Another patient of small cell carcinoma of urinary bladder developed stenosis at the urethra-neobladder junction, which was managed by optical dilatation.


  Conclusion Top


Although the study was limited to a single study site, this study provides extensive information on outcomes of bladder cancer undergoing radical cystectomy. Overall, the mortality and morbidity observed in this study were comparable to the high-volume centers. Studer's neobladder was easy to make, and it has favorable long-term outcome. Patient factors, surgeon's experience, and management of complications are key areas that must be critically assessed to select the appropriate diversion.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.



 
  References Top

1.
Cancer Stat Facts: Bladder Cancer. Available from: https://www.seer.cancer.gov/statfacts/html/urinb.html. [Last accessed on 2018 Feb 25].  Back to cited text no. 1
    
2.
Indian Council of Medical Research. Consolidated Report of Population-Based Cancer Registries 2001-2004. National Cancer Registry Programme. Bangalore: Indian Council of Medical Research; 2006.  Back to cited text no. 2
    
3.
Somani BK, Gimlin D, Fayers P, N'dow J. Quality of life and body image for bladder cancer patients undergoing radical cystectomy and urinary diversion – A prospective cohort study with a systematic review of literature. Urology 2009;74:1138-43.  Back to cited text no. 3
    
4.
Madeb R, Messing EM. Gender, racial and age differences in bladder cancer incidence and mortality. Urol Oncol 2004;22:86-92.  Back to cited text no. 4
    
5.
Huang GJ, Stein JP. Open radical cystectomy with lymphadenectomy remains the treatment of choice for invasive bladder cancer. Curr Opin Urol 2007;17:369-75.  Back to cited text no. 5
    
6.
Lowrance WT, Rumohr JA, Chang SS, Clark PE, Smith JA Jr., Cookson MS, et al. Contemporary open radical cystectomy: Analysis of perioperative outcomes. J Urol 2008;179:1313-8.  Back to cited text no. 6
    
7.
Konety BR, Joslyn SA, O'Donnell MA. Extent of pelvic lymphadenectomy and its impact on outcome in patients diagnosed with bladder cancer: Analysis of data from the surveillance, epidemiology and end results program data base. J Urol 2003;169:946-50.  Back to cited text no. 7
    
8.
Stein JP, Lieskovsky G, Cote R, Groshen S, Feng AC, Boyd S, et al. Radical cystectomy in the treatment of invasive bladder cancer: Long-term results in 1,054 patients. J Clin Oncol 2001;19:666-75.  Back to cited text no. 8
    
9.
Dalbagni G, Genega E, Hashibe M, Zhang ZF, Russo P, Herr H, et al. Cystectomy for bladder cancer: A contemporary series. J Urol 2001;165:1111-6.  Back to cited text no. 9
    
10.
Madersbacher S, Hochreiter W, Burkhard F, Thalmann GN, Danuser H, Markwalder R, et al. Radical cystectomy for bladder cancer today – A homogeneous series without neoadjuvant therapy. J Clin Oncol 2003;21:690-6.  Back to cited text no. 10
    
11.
Hautmann RE. The oncologic results of laparoscopic radical cystectomy are not (yet) equivalent to open cystectomy. Curr Opin Urol 2009;19:522-6.  Back to cited text no. 11
    
12.
Gupta NP, Ansari MS, Nabi G. National survey on orthotopic neobladder. Int Urol Nephrol 2007;39:143-8.  Back to cited text no. 12
    
13.
Hollenbeck BK, Miller DC, Taub D, Dunn RL, Khuri SF, Henderson WG, et al. Identifying risk factors for potentially avoidable complications following radical cystectomy. J Urol 2005;174:1231-7.  Back to cited text no. 13
    
14.
Chang SS, Cookson MS, Baumgartner RG, Wells N, Smith JA Jr. Analysis of early complications after radical cystectomy: Results of a collaborative care pathway. J Urol 2002;167:2012-6.  Back to cited text no. 14
    
15.
Bjerre BD, Johansen C, Steven K. Health-related quality of life after cystectomy: Bladder substitution compared with ileal conduit diversion. A questionnaire survey. Br J Urol 1995;75:200-5.  Back to cited text no. 15
    
16.
Yin M, Joshi M, Meijer RP, Glantz M, Holder S, Harvey HA, et al. Neoadjuvant chemotherapy for muscle-invasive bladder cancer: A systematic review and two-step meta-analysis. Oncologist 2016;21:708-15.  Back to cited text no. 16
    
17.
Sullivan LD, Chow VD, Ko DS, Wright JE, McLoughlin MG. An evaluation of quality of life in patients with continent urinary diversions after cystectomy. Br J Urol 1998;81:699-704.  Back to cited text no. 17
    
18.
Steers WD. Voiding dysfunction in the orthotopic neobladder. World J Urol 2000;18:330-7.  Back to cited text no. 18
    
19.
Boyd SD, Feinberg SM, Skinner DG, Lieskovsky G, Baron D, Richardson J, et al. Quality of life survey of urinary diversion patients: Comparison of ileal conduits versus continent Kock ileal reservoirs. J Urol 1987;138:1386-9.  Back to cited text no. 19
    



 
 
    Tables

  [Table 1], [Table 2], [Table 3], [Table 4]



 

Top
 
 
  Search
 
Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
Access Statistics
Email Alert *
Add to My List *
* Registration required (free)

 
  In this article
Abstract
Introduction
Methods
Results
Discussion
Conclusion
References
Article Tables

 Article Access Statistics
    Viewed771    
    Printed27    
    Emailed0    
    PDF Downloaded6    
    Comments [Add]    

Recommend this journal